Healthleap has raised $38 million across seed and Series A financing. The funding comprises an $8 million seed round co-led by Sequoia Capital and First Round Capital and a $30 million Series A led by Hummingbird Ventures.
The San Francisco-based company develops a clinical AI platform that analyzes hospital electronic health record data to identify patients who may be at risk of conditions that have not yet been diagnosed. Its system surfaces higher-risk patients for clinical review and is designed to integrate the findings into existing care workflows.
Healthleap is led by sibling co-founders Josiah Meyer, CEO, and Jemima Meyer, a clinical dietitian who developed the company’s original nutrition-focused tools. The platform began with malnutrition screening and has since expanded toward identifying risks across additional clinical conditions.
The company says its technology is now used across more than 50 hospitals, with health systems including Penn Medicine, Cedars-Sinai, Houston Methodist, Intermountain and Emory Healthcare among its customers.
Healthleap plans to use the new capital to expand its engineering, product, sales and customer success teams and develop screening capabilities for more conditions.
